Our Story

Since 2006, Spectrum Solutions has been a single-source provider of high-quality, direct-to-consumer product innovation & global fulfillment. For the last decade, Spectrum has found a specialized focus building on its medical and non-medical product development and manufacturing expertise by integrating complete test-to-treat partner solutions adding clinical laboratory testing with an onsite compounding pharmacy. Spectrum’s saliva diagnostic innovation has made such an impact within the life science sector it has been honored with several prestigious awards, received incredible industry and private sector recognition, and is directly responsible for the birth of a new billion-dollar saliva diagnostic industry.

Meet our Leadership Team

There is no replacement for the insights and value real product experience delivers. Exceptional experience starts early and builds. One idea, one project, one product launch after another.

Hover over each element below to discover and highlight a bit more information on a team, their big wins, and possibly a fun fact or two. Do we have the right experience, talent, and skill to advance your medical device program?

Yes, yes we do.

Bill Phillips

CHIEF EXECUTIVE OFFICER

As a founding partner of Spectrum Solutions, Mr. Phillips has spent 21 years focused on customer packaging, product engineering, and building an innovative customer-focused company. Under his leadership the company grew and evolved from the original two individuals to several hundred employees. His professional creativity and vast product manufacturing knowledge have earned him several industry awards and accolades as well as patents.

Dr. David J. Vigerust

CHIEF SCIENCE OFFICER

Dr. David J. Vigerust, MS., PhD., Spectrum’s Chief Scientific Officer, has a deep foundational and highly practical scientific knowledge across multiple disciplines in biotechnology, medicine, and life science. Dr. Vigerust holds a bachelor’s degree in biology and chemistry from the University of Texas at El Paso, a master’s degree in microbiology and immunology from Texas Tech University in Lubbock, and a Ph.D. in cellular and molecular pathology from Vanderbilt University in Nashville, TN.  Additionally, Dr. Vigerust conducted his post-doctoral research on viral glycosylation, host defense from influenza, and bacterial secondary infection in the Department of Infectious Disease at St. Jude Children’s Research Hospital. He completed a second post-doctoral fellowship at Vanderbilt University Medical School in the Department of Pediatric Infectious Disease in the area of molecular biology of respiratory viruses.